HomeInsightsPE

Bafna Pharmaceuticals Ltd PE Ratio

Bafna Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.1 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PE

303.9

Last updated: 19 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of Bafna Pharmaceuticals Ltd is 303.9 as of 19 Sep 15:30 PM.
  • The P/E Ratio of Bafna Pharmaceuticals Ltd changed from 0 on March 2019 to 0 on March 2020 . This represents a CAGR of 0.0% over 2 years. .
  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 79 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Bafna Pharmaceuticals Ltd

No data available

Company Fundamentals for Bafna Pharmaceuticals Ltd

No data available

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PRICE

79

0.50 (0.64%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 202479
18 Sep 202478.5
17 Sep 202478.62
16 Sep 202481.43
13 Sep 202479
12 Sep 202479.97
11 Sep 202481.5
10 Sep 202481.5
09 Sep 202477.74
06 Sep 202479.6

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Bafna Pharmaceuticals Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bafna Pharmaceuticals Ltd

No data available

* All values are in %

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a. Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990.
  • Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 202410:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 202417:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 202413:56

News

Bafna Pharmaceuticals to hold board meeting

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

28 May 202413:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

03 Feb 202414:11

News

Bafna Pharmaceuticals announces board meeting date

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

01 Nov 202317:06

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Bafna Pharmaceuticals Ltd

What is the current PE Ratio of Bafna Pharmaceuticals Ltd?

The Current PE Ratio of Bafna Pharmaceuticals Ltd is 303.85 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Bafna Pharmaceuticals Ltd last year?

The PE Ratio of Bafna Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 303.85, showing a year-on-year growth of -%.

What does the PE Ratio of Bafna Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Bafna Pharmaceuticals Ltd is 303.85. This ratio indicates that investors are willing to pay 303.85 times the earnings per share for each share of Bafna Pharmaceuticals Ltd.

What is the PE Ratio Growth of Bafna Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bafna Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -72.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*